Graybug Vision Initiates Phase 1/2 Trial of GB-102 for Wet Age-related Macular Degeneration
September 19, 2017 08:00 ET
|
Graybug Vision, Inc.
REDWOOD CITY, CA--(Marketwired - Sep 19, 2017) - Graybug Vision, Inc., a clinical-stage, venture-held pharmaceutical company committed to developing potentially transformative therapies for...
Graybug Vision CEO to Participate in OIS@ASRS Conference
August 08, 2017 08:00 ET
|
Graybug Vision, Inc.
REDWOOD CITY, CA--(Marketwired - Aug 8, 2017) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
Valerie Smith Joins Graybug Vision as VP, Global Clinical Development Operations
May 08, 2017 08:00 ET
|
Graybug Vision, Inc.
REDWOOD CITY, CA--(Marketwired - May 8, 2017) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
Graybug Vision's Potential Once-Per-Year AMD Treatment Data Presented at ARVO 2017
May 08, 2017 08:00 ET
|
Graybug Vision, Inc.
REDWOOD CITY, CA--(Marketwired - May 8, 2017) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
Graybug Vision to Present at the 16th Annual Needham Healthcare Conference on April 4
April 04, 2017 08:01 ET
|
Graybug Vision, Inc.
REDWOOD CITY, CA--(Marketwired - Apr 4, 2017) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
Graybug Vision CEO Jeffrey Cleland Discusses Company's Prodrug Technology at Glaucoma 360 on February 3
February 03, 2017 08:00 ET
|
Graybug Vision, Inc.
REDWOOD CITY, CA--(Marketwired - Feb 3, 2017) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
Graybug Vision Appoints Thomas S. Templeman, PhD, as Chief Operating Officer
January 03, 2017 08:00 ET
|
Graybug Vision, Inc.
REDWOOD CITY, CA--(Marketwired - Jan 3, 2017) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
Graybug Vision to Present at the 28th Annual Piper Jaffray Healthcare Conference
November 21, 2016 08:00 ET
|
Graybug Vision, Inc.
REDWOOD CITY, CA--(Marketwired - Nov 21, 2016) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
Graybug Vision Expands Executive Team With Appointments of Charles P. Semba, MD, and Ward M. Peterson, PhD
June 21, 2016 08:00 ET
|
Graybug Vision, Inc.
REDWOOD CITY, CA--(Marketwired - Jun 21, 2016) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
Graybug Vision GB-102 Toxicology/PK Study Presented at ARVO 2016
May 04, 2016 15:45 ET
|
Graybug Vision, Inc.
REDWOOD CITY, CA--(Marketwired - May 4, 2016) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...